Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

MEDIFAST INC

BTIG analyst Marie Thibault maintained a Buy rating on MiniMed Group, Inc. on June 15 and set a price target of $25.00. The company’s shares closed...

BTIG Remains a Buy on MiniMed Group, Inc. (MMED)

Jefferies analyst reiterated a Hold rating on Banca Mediolanum SpA today and set a price target of €21.50. Currently, the analyst consensus on Banc...

Banca Mediolanum SpA (BNMDF) Receives a Hold from Jefferies

Medpace Holdings Inc ($MEDP) announced an update on their ongoing clinical study. Medpace Holdings, Inc. is helping run a Phase 3 trial that tests ...

Pritelivir Trial Update Highlights Medpace’s Role in Drug-Resistant HSV Market

In a report released today, Daniel Markowitz CFA from Evercore ISI maintained a Buy rating on MiniMed Group, Inc., with a price target of $20.00. M...

Evercore ISI Remains a Buy on MiniMed Group, Inc. (MMED)

Medpace Holdings ( ($MEDP) ) has issued an announcement. Effective June 1, 2026, Medpace Holdings, Inc. appointed long-time executive Brad W. Hansm...

Medpace Elevates Brad Hansman to Executive Operations Role

The latest announcement is out from Globus Medical ( ($GMED) ). On June 3, 2026, Globus Medical stockholders approved an amendment to the company’s...

Globus Medical Expands Equity Plan, Elects New Directors

Medpace Holdings Inc ($MEDP) announced an update on their ongoing clinical study. The BEACON Phase III study, titled “A Randomized, Multi-center, D...

BEACON Phase III Rugonersen Trial Puts Medpace in Focus for Rare Disease Investors

Bank of America Securities analyst Travis Steed reiterated a Buy rating on MiniMed Group, Inc. today and set a price target of $20.00. Steed covers...

Bank of America Securities Sticks to Its Buy Rating for MiniMed Group, Inc. (MMED)

There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on MiniMed Group, Inc. (MMED) and Avalyn Pharma Inc (AVLN) with...

Analysts Are Bullish on These NA Stocks: MiniMed Group, Inc. (MMED), Avalyn Pharma Inc (AVLN)

The latest announcement is out from Medifast ( ($MED) ). On May 29, 2026, Medifast, Inc.’s Chief Legal Officer and Corporate Secretary, Jason L. Gr...

Medifast Announces Chief Legal Officer Resignation and Transition

The latest announcement is out from Medifast ( ($MED) ). On May 19, 2026, Medifast stockholders re-elected all seven directors to the board, ratifi...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MED	$11.54	+4.48%	149.24K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MED	$11.54	+4.5%	149.24K
3
4
5
6

MED

MED

Get MEDIFAST INC Data in Excel

Get MEDIFAST INC Data in Excel